Search Results - "Cubero, J Segovia"

Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country by López-Vilella, R, Bueno, M Gómez, Vílchez, F González, Jover, A Solé, Hernández, R Laporta, Guillén, R Vicente, Román, A I Gonzalez, Sánchez-Lázaro, I, Pérez, F Hernández, Badía, G Sales, Peláez, M D M Córdoba, Puerta, S Torregrosa, Gil, A teza, Dolz, L Martínez, Cubero, J Segovia, Bonet, L Almenar

“…HLTx presents notable differences with other transplants, especially related to its high mortality, which forces us to re-evaluate its usefulness according to…”
Get full text

Experience in anaesthetic management of non-cardiac surgery in patients with ventricular assist devices by Bobes, A Albajar, Salcedo, M Casado, Gómez-Limón, E Rincón, Álvarez Avello, J M, González Román, A I, Fernández, M Vidal, Gil, A Forteza, Gómez-Bueno, M, Cubero, J Segovia, Fernández, J García

“…Heart failure (HF) is a syndromic condition with a high incidence in current medicine. When the symptoms of HF progress, and become refractory, cardiac…”
Get full text

Potential Role of Donor-Derived Cell Free DNA as a New Biomarker in Cardiac Allograft Vasculopathy (FreeDNA-CAV) by Jimenez-Blanco Bravo, M., Perez Gomez, L., Arellano Serrano, C., Torres Sanabria, M., Hernandez Perez, F., Oteo Dominguez, J., Mingo Santos, S., Mitroi, C., Moñivas Palomero, V., Gomez Bueno, M., Segovia Cubero, J.

“…There is an unmet need for a noninvasive biomarker for cardiac allograft vasculopathy (CAV), that could obviate the need to perform surveillance coronary…”
Get full text

Pulmonary Artery Pulsatility Index as a Predictor of Right Ventricular Disfunction After Left Ventricular Assist Device Implantation by Mingo Santos, S, Moñivas Palomero, V, Durante Lopez, A, Oteo Dominguez, J.F, Vilches Soria, S, Gomez Bueno, M, Hernandez Perez, F, Goirigolzarri Artaza, J, Alonso Pulpon, L, Serrano Fiz, S, Segovia Cubero, J

Get full text

Should We Amplify Cardiac Response Criteria in Patients with Cardiac Light-Chain Amyloidosis Treated with Bortezomib? by Vázquez, J, Durante, A, Hernández, F, Moñivas Palomero, V, Mingo, S, Sayago, I, García Pavía, P, Alonso-Pulpón, L, Segovia Cubero, J

Get full text

Usefulness of severity scales for cardiogenic shock in-hospital mortality. Proposal for a new prognostic model by Álvarez-Avello, J.M., Hernández-Pérez, F.J., Herrero-Cano, Á., López-Ibor, J.V., Aymerich, M., Iranzo, R., Vidal-Fernández, M., Gómez-Bueno, M., Gómez-Paratcha, B., García-Suárez, J., Martín, C.E., Forteza, A., González-Román, A., Segovia-Cubero, J.

“…Cardiogenic shock (CS) is a condition comprising multiple etiologies, which associates high mortality rates. Some scoring systems have been shown to be good…”
Get full text

Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country by Lopez-Vilella, R, Gomez Bueno, M, Gonzalez Vflchez, F, Sole Jover, A, Laporta Hernandez, R, Vicente Guillen, R, Gonzalez Roman, A I, Sanchez-Lazaro, I, Hernandez Perez, F, Sales Badfa, G, Cordoba Pelaez, M D M, Torregrosa Puerta, S, teza Gil, A, Martinez Dolz, L, Segovia Cubero, J, Almenar Bonet, L

“…BackgroundThis study aims to evaluate the entire experience in heart-lung transplantation (HLTx) in a country of the European Union with 47 million inhabitants…”
Get full text

Neoplasia after Heart Transplantation. Differences in Incidence and Prognosis between Genders. Data from the Spanish Post-Heart Transplant Tumor Registry by Crespo-Leiro, M.G, Segovia Cubero, J, Delgado-Jiménez, J.F, Roig-Minguell, E, Barge-Caballero, E, Sousa-Casasnovas, I, Almenar-Bonet, L, González-Vilchez, F, González-Costello, J, Díaz-Molina, B, Sobrino-Márquez, J.M, Rábago, G, Arizón del Prado, J.M, Pérez-Villa, F, Blasco Peiró, T, de la Fuente-Galán, L, Garrido Bravo, I.P, Muñiz, J

Get full text

680 Long Term Results with Bosentan Treatment in Pulmonary Hypertension by Segovia Cubero, J, Avellana Calvo, P.M, Sufrate Sorzano, E, Gomez Bueno, M, García-Pavía, P., M.D, Cosio Carmena, G, Gutierrez Landaluce, C, Alonso Pulpón, L.A

Get full text

214. Asistencia ventricular thoratec® y berlin heart® como puente al trasplante by Castedo Mejuto, E, Ramis Pocovi, S, Martínez Cabeza, P, López Fernández, J, Serrano-Fiz García, S, García Montero, C, Burgos Lázaro, R, Gómez Bueno, M, Segovia Cubero, J, Alonso Pulpón, L, Ugarte Basterrechea, J

“…La disminución del número de donantes en España ha motivado una prolongación del tiempo de permanencia en lista de espera de trasplante cardíaco (TC). Por…”
Get full text

220. Asistencia univentricular izquierda Berlin heart como puente al trasplante en pacientes con hipertensión pulmonar grave by Martínez Cabeza, P, Castedo Mejuto, E, Ramis Pocovi, S, López Fernández, J, Serrano-Fiz García, S, García Montero, C, Burgos Lázaro, R.J, Gómez Bueno, M, Segovia Cubero, J, Pulpón, L.A, Ugarte Basterrechea, J

“…La hipertensión pulmonar (HTP) grave es un factor de riesgo de mortalidad perioperatoria durante el trasplante cardíaco (TC). Los pacientes con HTP refractaria…”
Get full text

Donor-derived cell-free DNA kinetics in the first year post-transplant in patients without acute cellular rejection by Jimenez-Blanco Bravo, M, Crespo Leiro, M, Gonzalez Sardinero, E, Gomez Bueno, M, Lopez Villela, R, Ortiz Bautista, C, Farrero, M, Maestro Benedicto, A, Diaz Molina, B, Diez Lopez, C, Rangel Sousa, D, Salterain, N, Garrido Bravo, I, Segovia Cubero, J

Get full text

Role of NTproBNP and donor-derived cell-free DNA in the diagnosis of acute rejection in heart transplant recipients: a prospective study by Jimenez-Blanco Bravo, M, Crespo Leiro, M, Marco Clement, I, Lozano Jimenez, S, Donoso, V, Ortiz Bautista, C, Farrero, M, De Antonio, M, Diaz Molina, B, Diez Lopez, C, Rangel Sousa, D, Salterain, N, Garrido Bravo, I, Segovia Cubero, J

Get full text

(1141) - An Elusive Chagas Reactivation Mimicking an Acute Cellular Rejection After a Heart Transplant: The Importance of Pursuing the Diagnosis by Martín-Centellas, A., Hernandez Perez, F., Gil Bernabe, P., Rivas-Lasarte, M., Mitroi, C., Garrido Gonzalez, R., Matutano Muñoz, A., Gomez Bueno, M., Salas Anton, C., Segovia-Cubero, J.

Get full text

Prospective evaluation of donor-derived cell-free DNA as a potential biomarker for cardiac allograft vasculopathy by Jimenez-Blanco Bravo, M, Perez Gomez, L, Arellano Serrano, C, Hernandez Perez, F.J, Gomez Bueno, M, Torres Sanabria, M, Segovia Cubero, J

Get full text

Short-pulse of systemic steroids in acute pericarditis: an alternative in refractory cases by Sanchez Arjona, A, Fernando Dominguez Rodriguez, F D R, Juan Carlos Lopez Azor, J C L A, Marta Cobo Marcos, M C M, Gabriela Uriarte Zabala, G U Z, Alejandro Nistal Juarez, A N J, Pablo Garcia Pavia, P G P, Javier Segovia Cubero, J S C

Get full text

Donor-derived cell-free DNA as a new biomarker for acute rejection in heart transplant recipients: results from the freedna car study by Jimenez-Blanco Bravo, M, Crespo Leiro, M, Garcia Cosio, M D, Hernandez Perez, F J, Lopez Villela, R, Ortiz Bautista, C, Farrero, M, Zegri Reiriz, I, Diaz Molina, B, Diez Lopez, C, Rangel Sousa, D, Salterain, N, Garrido Bravo, I, Segovia Cubero, J

Get full text

Cardiac allograft vasculopathy and acute rejection surveillance in the same procedure through a single vascular access. High volume center experience by Arellano Serrano, C, Oteo Dominguez, J.F, Garcia Touchard, A, Fernandez Diaz, J.A, Del Trigo Espinosa, M, Mitroi, C, Hernandez Perez, F.J, Gomez Bueno, M, Goicolea Ruigomez, J, Segovia Cubero, J

Get full text

(768) - Mitigating Risk by Using the Primary Graft Dysfunction-Artificial Intelligence (PGD-AI) Calculator in a Contemporary Toronto Cohort: An Analysis from The International Consortium on PGD by Moayedi, Y., Raslan, I., Venkatraman, A., Foroutan, F., Truby, L., Han, J., Henricksen, E., Guzman Bofarull, J., Couto Mallon, D., Moayedifar, R., Luikart, H., Kim, G., Crespo-Leiro, M., Felius, J., Hall, S., Devore, A., Sabatino, M., Potena, L., Rivas-Lasarte, M., Segovia-Cubero, J., Farrero Torres, M., Tremblay-Gravel, M., Noly, P., Miller, R., Chih, S., Zuckermann, A., Clarke, B., Khush, K., Fan, C., Ross, H.

Get full text

Is Donor-Derived Cell Free DNA a Useful Biomarker of Cardiac Allograft Vasculopathy? (FreeDNA-CAV Study) by Bravo, M. Jimenez-Blanco, Gómez, L. Pérez, Pérez, F. Hernández, Sanabria, M. Torres, Serrano, C. Arellano, Bueno, M. Gómez, Cubero, J. Segovia

“…To evaluate the performance of Donor-derived Cell Free DNA (ddcf-DNA) as a biomarker of cardiac allograft vasculopathy (CAV) in a cohort of heart transplant…”
Get full text